mRNA Investigational Vaccine Study

Now Enrolling

Meridian is now seeking participants for an investigational mRNA vaccine study.

In this study, scientists are evaluating investigational mRNA vaccines intended to help prevent the spread of several diseases, including COVID-19, influenza, cytomegalovirus (CMV), and respiratory syncytial virus (RSV).

Eligible participants…

  • Must be age 18-75
  • Will receive an investigational COVID-19, RSV, or CMV vaccine, OR an FDA-approved seasonal flu vaccine at no cost
  • Must NOT have received a seasonal flu vaccine within the past 6 months
  • Could receive up to $900 compensation for study-related time
  • Do not need insurance to join this study

About the Diseases Being Studied

  • RSV can cause infections of the lungs and respiratory tract and can lead to serious conditions such as pneumonia and bronchiolitis, especially for seniors and immunocompromised people. RSV hospitalizes an estimated 177,000 seniors (age >65) in the U.S. each year.
  • CMV is a common virus. Although most children and adults don’t experience symptoms, CMV infection before or during birth in newborns (congenital CMV infection) can result in significant lifelong disability. CMV is the most common infectious cause of birth defects in the U.S.
  • Influenza is an infectious disease characterized by the abrupt onset of respiratory and systemic symptoms, such as fever, cough, sore throat, and rhinitis. Research studies are crucial, especially for advancing research of investigational vaccines to protect older adults and persons with underlying medical conditions.
  • Cold- or flu-like symptoms — such as fever, cough, shortness of breath, fatigue, muscle pain, headache, and chills — are common with SARS-CoV-2 infection (COVID-19). Severe cases can lead to pneumonia, other respiratory conditions, and organ dysfunction or failure.

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.

You can talk to a Meridian enrollment specialist about this study by calling (712) 639-6200 (Lincoln, Sioux City) or (912) 623-2240 (Binghamton, Savannah).

Expect Excellence icon - supporting research since 1999

Submit your information

Study Locations


  • Savannah: Meridian Clinical Research, 340 Eisenhower Dr #1500, Savannah, GA 31406


  • Sioux City: Meridian Clinical Research, 4802 Sunnybrook Dr., Sioux City, IA 51106


  • Lincoln: Meridian Clinical Research, 4600 Valley Rd., Lincoln, NE 68510

New York

  • Endwell: Meridian Clinical Research, 415 Hooper Road, Endwell, NY 13760
  • Binghamton: 1290 Upper Front Street, Binghamton, NY 13901

Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.